Evidence Building
Does Raising Venture Capital Help Your O-1 Visa Case?
VC funding can demonstrate high remuneration and critical role, but it's not automatic. Learn how to position your fundraising as evidence.
Why VC Funding Matters Even Though It Is Not a Criterion
Venture capital fundraising is not one of the eight regulatory criteria listed at 8 CFR 214.2(o)(3)(iii)(B). You will not find 'raised a Series A' or 'closed a seed round' anywhere in the statute or the regulations. Despite that, USCIS has, since the 2022 Policy Manual update at Volume 2, Part M, Chapter 4, explicitly listed venture capital fundraising as a type of evidence that can support an O-1A petition for a founder. The reason is that VC funding is independent third-party validation, and adjudicators are trained to give substantial weight to evidence that does not come from the petitioner's own pen.
When a top-tier venture firm, after weeks of due diligence, writes a check for several million dollars at a valuation that rewards the founder's prior work, that decision functions as a peer review. The investor is staking real capital on the proposition that the founder has produced something significant and is positioned to produce more. USCIS adjudicators recognize this and will count well-documented VC investment toward the original contribution criterion, the critical role criterion, and, in some cases, the high-remuneration criterion (when the round triggers a salary increase or bonus).
That said, raising VC is neither necessary nor sufficient. Founders without any institutional funding have won O-1A approvals on the strength of patents, press, and customer adoption. Founders who have raised hundreds of millions have received RFEs and even denials when their petitions failed to translate the funding into the language of the regulations. The question is not whether VC helps but how to use it correctly.
Mapping VC Evidence to the Regulatory Criteria
VC funding most naturally supports the original contribution of major significance criterion at 8 CFR 214.2(o)(3)(iii)(B)(5). The argument runs: a sophisticated investor performed due diligence, concluded that the founder's product or technical contribution had major significance to the field, and committed capital on that basis. To make this argument credible, the petition should include the term sheet (with confidential financial terms redacted if necessary), the executed Series A or seed financing documents, and, most importantly, a letter from the lead investor explaining what they invested in and why.
An investor letter should not simply confirm the existence of the round. It should explain the founder's specific contributions, identify the alternative companies the investor evaluated and why they passed, and describe how the founder's work compares to the broader field. A well-drafted investor letter from a partner at Sequoia, Founders Fund, or Greylock will read more like an expert declaration than a marketing email. Counsel should provide investors with a one-page brief that explains the regulatory standard and asks specific questions tied to the criteria.
VC funding also supports the critical role criterion at 8 CFR 214.2(o)(3)(iii)(B)(8). A founder who raised $20 million from a tier-one fund is, by definition, in a critical role at an organization with a distinguished reputation, because the funding itself helps establish the company's reputation. Pair the term sheet with a board resolution naming the founder as CEO and an organizational chart showing how the company has scaled since the round. If the funding triggered a hiring round that grew the team from 5 to 25, document the growth and the founder's central role in driving it.
What Counts as a Distinguished Investor
Not all venture capital is treated equally by USCIS adjudicators. A check from Y Combinator, Andreessen Horowitz, Sequoia, Benchmark, or a similarly recognized firm carries presumptive weight because the firm itself has a public track record. The petition should include exhibits documenting the firm's reputation: a Forbes Midas List ranking, AUM figures, notable portfolio exits (Airbnb, Stripe, Coinbase, Instacart), and a description of the firm's selectivity (e.g., funding fewer than 1 percent of pitches received).
Funding from less well-known firms can still be useful, but requires more setup. If the lead investor is a sector-specialist fund focused on robotics, biotech, or fintech, document why that specialization makes the firm's diligence particularly authoritative for the founder's space. Include the firm's portfolio, prior exits, and any media coverage of the firm itself. A small fund led by partners who previously sold companies to Google or Meta is far more impressive when those credentials are made explicit in the petition than when the firm is mentioned in passing.
Angel investors and rolling funds are weaker evidence on their own, but become powerful when aggregated. A SAFE round with 30 angels including former CTOs of public companies, founders of unicorn startups, and well-known operators can substitute for a single tier-one lead. Build a one-page exhibit listing each angel, their professional background, and the size of their check. The cumulative effect approaches the credibility of an institutional round.
Common Mistakes With VC-Heavy Petitions
The first common mistake is letting the funding speak for itself. A petition that includes a TechCrunch article announcing a $15 million Series A and stops there is missing the point. The funding is the headline, but the evidence USCIS needs is the underlying due diligence: what did the investor evaluate, why did they choose this founder over alternatives, and what does the funding say about the founder's standing in the field? Without that connective tissue, an adjudicator may treat the round as background context rather than evidence of extraordinary ability.
The second mistake is overweighting the funding relative to the founder's individual contributions. The O-1 is a visa for individuals, not companies. If the petition spends 40 pages on the company's traction and 4 pages on what the founder personally did, an adjudicator will reasonably ask what part of the company's success is attributable to the founder versus the rest of the team, the market, or the timing. Always tie company milestones back to specific actions the founder took: the architecture decision they made, the customer they personally closed, the technical insight that became the patent.
The third mistake is conflating valuation with significance. A unicorn valuation is not, by itself, evidence of extraordinary ability under the regulations. USCIS adjudicators have approved O-1A petitions for founders of pre-revenue startups and denied petitions for founders of decacorns. The valuation is useful context, but the petition must still demonstrate the founder's individual contributions across at least three of the eight criteria. Treat the valuation as supporting evidence, not as a substitute for the substantive analysis.
Real-World Tips for Using VC Evidence
When working with investors, request a letter early and provide a draft. Investor partners are busy and will rarely write a strong letter from scratch in time for a filing deadline. Counsel should prepare a 1.5-page draft tailored to the founder's evidence, send it to the investor's deal partner with a short cover note explaining the regulatory context, and follow up at the two-week mark. The investor should personalize the letter and add specific deal-related details (diligence calls, customer references, technical reviews) that only they can speak to.
Document the round in layers. Include the TechCrunch or Bloomberg announcement, the term sheet, the executed financing agreement (with sensitive terms redacted under a confidentiality stipulation), the cap table showing the founder's continued ownership, and a board resolution from after the round closes. This stack tells the adjudicator a complete story: the press validated the round publicly, the legal documents prove it actually closed, and the cap table demonstrates that the founder remains in a critical role with material economic stake.
Finally, use the round to upgrade other criteria. After a Series A, founders often join other companies' boards, judge accelerator demo days, mentor at YC, or speak at major industry conferences. Each of these activities maps onto the judging criterion at 8 CFR 214.2(o)(3)(iii)(B)(4). The funding event itself will be reported in TechCrunch, Forbes, Bloomberg, and trade press, generating evidence for the published material criterion at 8 CFR 214.2(o)(3)(iii)(B)(3). A well-timed petition filed six months after a Series A captures all these downstream benefits, not just the round itself.